Home/Filings/4/0001072613-05-000009
4//SEC Filing

DAFTARI SHAILESH V 4

Accession 0001072613-05-000009

CIK 0000857171other

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 5:12 PM ET

Size

7.3 KB

Accession

0001072613-05-000009

Insider Transaction Report

Form 4
Period: 2004-12-30
DAFTARI SHAILESH V
E.V.P. and General Manager
Transactions
  • Conversion

    Common Stock

    2004-12-30+14,67517,008 total
  • Conversion

    Series Q Preferred Stock

    2004-12-302500 total
    Common Stock (14,675 underlying)
Footnotes (3)
  • [F1]Shares acquired upon conversion of Series Q Preferred Stock.
  • [F2]Each share of Series Q Preferred Stock converts into approximately 58.70 shares of common stock.
  • [F3]Immediately.

Issuer

ABLE LABORATORIES INC

CIK 0000857171

Entity typeother

Related Parties

1
  • filerCIK 0001246440

Filing Metadata

Form type
4
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 5:12 PM ET
Size
7.3 KB